VeraCept and LevoCept

ContraMed is committed to advancing birth control options for women. Using rigorous science, engineering and pharmacology expertise, ContraMed is leading the way in innovation with an acute focus on providing distinct advantages over existing intrauterine devices.

We are developing a new generation of both hormone-free (VeraCept) and hormone-based (LevoCept) devices, delivered on a singular, state of the art platform, which will offer clinical and procedural advantages for women and their health care providers.

CAUTION: New Drug- Limited by Federal Law to Investigational Use.

Learn More About VeraCept

Learn More About LevoCept